JP2025508429A5 - - Google Patents

Info

Publication number
JP2025508429A5
JP2025508429A5 JP2024548620A JP2024548620A JP2025508429A5 JP 2025508429 A5 JP2025508429 A5 JP 2025508429A5 JP 2024548620 A JP2024548620 A JP 2024548620A JP 2024548620 A JP2024548620 A JP 2024548620A JP 2025508429 A5 JP2025508429 A5 JP 2025508429A5
Authority
JP
Japan
Prior art keywords
receptor
vector
neuron
composition according
manipulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024548620A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508429A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062859 external-priority patent/WO2023159208A2/en
Publication of JP2025508429A publication Critical patent/JP2025508429A/ja
Publication of JP2025508429A5 publication Critical patent/JP2025508429A5/ja
Pending legal-status Critical Current

Links

JP2024548620A 2022-02-18 2023-02-17 神経学的疾患のための組成物および方法 Pending JP2025508429A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263311817P 2022-02-18 2022-02-18
US63/311,817 2022-02-18
PCT/US2023/062859 WO2023159208A2 (en) 2022-02-18 2023-02-17 Compositions and methods for neurological diseases

Publications (2)

Publication Number Publication Date
JP2025508429A JP2025508429A (ja) 2025-03-26
JP2025508429A5 true JP2025508429A5 (https=) 2026-02-26

Family

ID=87578990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024548620A Pending JP2025508429A (ja) 2022-02-18 2023-02-17 神経学的疾患のための組成物および方法

Country Status (7)

Country Link
US (1) US20250152742A1 (https=)
EP (1) EP4479420A2 (https=)
JP (1) JP2025508429A (https=)
CN (1) CN119137144A (https=)
AU (1) AU2023222147A1 (https=)
CA (1) CA3252389A1 (https=)
WO (1) WO2023159208A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025054256A1 (en) * 2023-09-06 2025-03-13 Tenaya Therapeutics, Inc. Targeting peptides, engineered aav capsid proteins and virions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10538571B2 (en) * 2017-11-27 2020-01-21 Coda Biotherapeutics, Inc. Compositions and methods for neurological diseases

Similar Documents

Publication Publication Date Title
JP2022545226A5 (https=)
JP2023503455A5 (https=)
JP6832280B2 (ja) 新規のマイクロジストロフィンおよび使用の関連する方法
Ziemssen et al. Glatiramer acetate: mechanisms of action in multiple sclerosis
JP2021503960A5 (https=)
US20050032219A1 (en) Methods of administering vectors to synaptically connected neurons
RU2018112506A (ru) Лечение пигментного ретинита
RU2019103488A (ru) Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12
JP2024513949A5 (https=)
Okun et al. Gene therapy for neurological disorders: challenges and future prospects for the use of growth factors for the treatment of Parkinson's disease
JP2023538130A5 (https=)
RU2019126509A (ru) Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе
JP2025508429A5 (https=)
Nakamura et al. Mesenchymal stem cells as a potential therapeutic tool for spinocerebellar ataxia
JP2022512579A5 (https=)
JP2022513454A (ja) ＡＩＭＰ２－ＤＸ２およびｍｉＲ－１４２の標的核酸を含むベクター、ならびにその使用
CN116368157A (zh) 用于溶解蛋白质聚集体的组合物和方法
JP2021534206A5 (https=)
JP2020533968A (ja) 組換えアデノ随伴ベクター
TW202033768A (zh) 腺相關病毒對cln6聚核苷酸的遞送
JP2021534206A (ja) Ｇｓｘ１を使用した脊髄損傷（ｓｃｉ）および脳損傷の処置
JP2024505197A5 (https=)
KR20230079267A (ko) AIMP2-DX2 및 선택적으로 miR-142에 대한 표적 서열 및 이의 조성물을 이용한 신경질환의 치료방법
JP2025508427A5 (https=)
JP2021536461A5 (https=)